Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
At week 20, the change from baseline in HbA1c in patients treated with sitagliptin (N=95) was 0.06% compared to 0.23% in patients treated with placebo (N=95), a difference of -0.17% (95% CI: -0.62, 0.28)
Accessed September 8, 2014
By requiring prior authorization, insurers aim to: Ensure the appropriate use of expensive medications
The findings provide crucial data, according to the researchers, to inform ongoing discussions about balancing the sustainability of health care spending against improving accessibility and affordability of GLP-1 RA medications moving forward. The trend directly informs current debates surrounding insurance coverage policies for weight-loss treatments, highlighting the challenge of reconciling costs with clinical demand and benefit
Regular follow-ups help catch symptoms early and ensure your plan stays safe and effective
Genitourinary syndrome of menopause (GSM) is driven by low or fluctuating oestrogen and is characterised by vulvovaginal dryness, irritation, dyspareunia, recurrent infections/urinary symptoms, and tissue fragility
US$ 29.59
US$ 27.96
US$ 23.21
US$ 25.09
